Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
View ORCID ProfileKaja Abbas, View ORCID ProfileSimon R Procter, View ORCID ProfileKevin van Zandvoort, Andrew Clark, View ORCID ProfileSebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, View ORCID ProfileMark Jit, View ORCID ProfileStefan Flasche
doi: https://doi.org/10.1101/2020.05.19.20106278
Kaja Abbas
1London School of Hygiene & Tropical Medicine
Simon R Procter
1London School of Hygiene & Tropical Medicine
Kevin van Zandvoort
1London School of Hygiene & Tropical Medicine
Andrew Clark
1London School of Hygiene & Tropical Medicine
Sebastian Funk
1London School of Hygiene & Tropical Medicine
1London School of Hygiene & Tropical Medicine
Tewodaj Mengistu
2Gavi, the Vaccine Alliance
Dan Hogan
2Gavi, the Vaccine Alliance
Emily Dansereau
3Bill & Melinda Gates Foundation
Mark Jit
1London School of Hygiene & Tropical Medicine
4Public Health England
5University of Hong Kong
Stefan Flasche
1London School of Hygiene & Tropical Medicine
Data Availability
The program code and data for the benefit-risk analysis conducted in this study is accessible on GitHub (https://github.com/vaccine-impact/epi_covid).
Posted June 24, 2020.
Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
Kaja Abbas, Simon R Procter, Kevin van Zandvoort, Andrew Clark, Sebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, Mark Jit, Stefan Flasche
medRxiv 2020.05.19.20106278; doi: https://doi.org/10.1101/2020.05.19.20106278
Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa
Kaja Abbas, Simon R Procter, Kevin van Zandvoort, Andrew Clark, Sebastian Funk, LSHTM CMMID CMMID COVID-19 Working Group, Tewodaj Mengistu, Dan Hogan, Emily Dansereau, Mark Jit, Stefan Flasche
medRxiv 2020.05.19.20106278; doi: https://doi.org/10.1101/2020.05.19.20106278
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (629)
- Anesthesia (166)
- Cardiovascular Medicine (2391)
- Dermatology (207)
- Emergency Medicine (380)
- Epidemiology (11786)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3758)
- Geriatric Medicine (350)
- Health Economics (636)
- Health Informatics (2403)
- Health Policy (935)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (366)
- Medical Ethics (105)
- Nephrology (400)
- Neurology (3517)
- Nursing (199)
- Nutrition (528)
- Oncology (1828)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1035)
- Primary Care Research (423)
- Public and Global Health (6160)
- Radiology and Imaging (1283)
- Respiratory Medicine (830)
- Rheumatology (379)
- Sports Medicine (324)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)